XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED CONDENSED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Accounting Standards Update 2016-13
Other loans, including deposit overdrafts [Member]
Other loans, including deposit overdrafts [Member]
OAEM [Member]
Common Stock [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings [Member]
Accounting Standards Update 2016-13
Treasury Stock, Common
Treasury Stock, Common
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income [Member]
Accumulated Other Comprehensive Income [Member]
Cumulative Effect, Period of Adoption, Adjustment
Balance Beginning (in shares) at Dec. 31, 2021           12,414,956                
Balance beginning at Dec. 31, 2021 $ 238,604         $ 143,130   $ 126,312     $ (29,029)   $ (1,809)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income 15,720             15,720            
Other comprehensive income, net of taxes (29,800)                       (29,800)  
Dividend Reinvestment and Stock Purchase Plan (in shares)           18,585                
Dividend Reinvestment and Stock Purchase Plan 308         $ 308                
Compensation expense relating to restricted stock (in shares)           32,554                
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 417         $ 417                
Dividends, Common Stock, Cash (6,830)             (6,830)            
Treasury shares purchased (in shares)           (1,172,456)                
Repurchase of common stock (22,980)                   (22,980)      
Balance Ending (in shares) at Sep. 30, 2022           11,293,639                
Balance ending at Sep. 30, 2022 $ 195,439         $ 143,855   135,202     (52,009)   (31,609)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Dividends declared per common share (usd per share) $ 0.60                          
Balance Beginning (in shares) at Jun. 30, 2022           11,374,515                
Balance beginning at Jun. 30, 2022 $ 202,960         $ 143,635   131,894     (50,629)   (21,940)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income 5,579             5,579            
Other comprehensive income, net of taxes (9,669)                       (9,669)  
Dividend Reinvestment and Stock Purchase Plan (in shares)           6,857                
Dividend Reinvestment and Stock Purchase Plan 107         $ 107                
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 113         $ 113                
Dividends, Common Stock, Cash (2,271)             (2,271)            
Treasury shares purchased (in shares)           (87,733)                
Repurchase of common stock (1,380)                          
Balance Ending (in shares) at Sep. 30, 2022           11,293,639                
Balance ending at Sep. 30, 2022 $ 195,439         $ 143,855   135,202     (52,009)   (31,609)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Dividends declared per common share (usd per share) $ 0.20                          
Financing Receivable, Revolving, Converted to Term Loan $ 6,056     $ 0 $ 0                  
Balance Beginning (in shares) at Dec. 31, 2022 11,259,080         11,259,080 11,259,080              
Balance beginning at Dec. 31, 2022 $ 200,675 $ 198,753 $ (1,922)     $ 144,069 $ 144,069 139,249 $ 137,327 $ (1,922) (52,689) $ (52,689) (29,954) $ (29,954)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income 12,921             12,921            
Other comprehensive income, net of taxes (758)                       (758)  
Dividend Reinvestment and Stock Purchase Plan (in shares)           20,065                
Dividend Reinvestment and Stock Purchase Plan 315         $ 315                
Compensation expense relating to restricted stock (in shares)           44,150                
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 481         $ 481                
Dividends, Common Stock, Cash (7,037)             (7,037)            
Treasury shares purchased (in shares)           (199,913)                
Repurchase of common stock $ (3,326)                   (3,326)      
Balance Ending (in shares) at Sep. 30, 2023 11,123,382         11,123,382                
Balance ending at Sep. 30, 2023 $ 201,349         $ 144,865   143,211     (56,015)   (30,712)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Dividends declared per common share (usd per share) $ 0.63                          
Balance Beginning (in shares) at Jun. 30, 2023           11,116,080                
Balance beginning at Jun. 30, 2023 $ 202,316         $ 144,671   141,431     (56,015)   (27,771)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income 4,070             4,070            
Other comprehensive income, net of taxes (2,941)                       (2,941)  
Dividend Reinvestment and Stock Purchase Plan (in shares)           7,302                
Dividend Reinvestment and Stock Purchase Plan 111         $ 111                
Compensation expense relating to restricted stock (in shares)           0                
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 83         $ 83                
Dividends, Common Stock, Cash (2,290)             (2,290)            
Treasury shares purchased (in shares)           0                
Repurchase of common stock $ 0                          
Balance Ending (in shares) at Sep. 30, 2023 11,123,382         11,123,382                
Balance ending at Sep. 30, 2023 $ 201,349         $ 144,865   $ 143,211     $ (56,015)   $ (30,712)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Dividends declared per common share (usd per share) $ 0.21                          
Financing Receivable, Revolving, Converted to Term Loan $ 387     $ 0 $ 0